Skip to content

ZTS

Zoetis Inc.

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US

$75.81
−0.63%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue9.5B9.5B9.3B8.5B8.1B
Cost of Revenue2.8B2.8B2.9B2.7B2.6B
Gross Profit6.7B6.7B6.4B5.8B5.5B
Operating Expenses
R&D Expense722.0M698.0M686.0M614.0M539.0M
SG&A Expense2.4B2.4B2.3B2.2B2.0B
General & Admin Expense2.0B
Selling & Marketing Expense302.0M
Other Expenses124.0M
Total Operating Expenses3.2B3.1B3.0B2.8B2.5B
Cost and Expenses6.0B5.9B5.9B5.5B5.2B
Operating Income (EBIT)3.5B3.6B3.4B3.1B2.9B
Non-Operating
Interest Income72.0M93.0M106.0M105.0M50.0M
Interest Expense244.0M243.0M242.0M258.0M237.0M
Net Interest Income(172.0M)(150.0M)(136.0M)(153.0M)(187.0M)
Other Non-Op Income/Expense(249.0M)(237.0M)(259.0M)(133.0M)(272.0M)
Non-Operating Income (excl Interest)11.0M15.0M17.0M(125.0M)35.0M
EBT (Pre-Tax Income)3.3B3.4B3.1B2.9B2.7B
Income Tax Expense656.0M687.0M637.0M596.0M545.0M
Bottom Line
Net Income2.6B2.7B2.5B2.3B2.1B
Earnings from Cont. Ops2.6B2.7B2.5B2.3B2.1B
Earnings from Discont. Ops
Bottom Line Net Income2.6B2.7B2.5B2.3B2.1B
Per Share
Basic EPS$6.08$6.03$5.47$5.08$4.51
Diluted EPS$6.07$6.02$5.47$5.07$4.49
Revenue Per Share$22.79$21.35$20.38$18.53$17.23
Shares
Basic Shares Outstanding417.6M443.4M454.2M461.2M468.9M
Diluted Shares Outstanding417.7M443.8M454.8M462.3M470.4M
Profitability Metrics
EBITDA3.9B4.1B3.9B3.7B3.4B
D&A364.0M487.0M497.0M491.0M465.0M
EBIT3.5B3.6B3.4B3.2B2.9B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026